ASPC 2018 Congress on CVD Prevention

 

ASPC 2018 Congress on CVD Prevention
Avatar

Debate – Pro – Lipoprotein(a) – Should Be Measured In All Patients At Higher CVD Risk

By ASPC 2018 Congress on CVD Prevention FEATURING Patrick Moriarty
By ASPC 2018 Congress on CVD Prevention FEATURING Patrick Moriarty
0 views
August 10, 2018
Comments 2
Login to view comments. Click here to Login

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Featured Video

15:01
Lilly Diabetes

Discover the MOA of an Incretin Medication for T2D

SESSION 8 - Debate Potpourri/Debate
25:28
ASPC 2018 Congress on CVD Prevention

What We Know and Don’t Know About Coronary Artery Calcium Imaging

Feat. K. Nasir
24:39
ASPC 2018 Congress on CVD Prevention

Screening and Anticoagulation for Afib – New Options and Opportuniti…

16:12
ASPC 2018 Congress on CVD Prevention

Debate – Pro – Lipoprotein(a) – Should Be Measured In All Patients A…

Feat. P. Moriarty
13:27
ASPC 2018 Congress on CVD Prevention

Debate – Con – Lipoprotein(a) – There is Nothing You Can Do About It…

Feat. S. Fazio
12:33
ASPC 2018 Congress on CVD Prevention

ASPC 2018 Congress on CVD Prevention: Discussion